SU 11248 (Tyrosine Kinases Inhibitors)
nanuk
Member Posts: 1,358 Member
Anybody out there involved in a SU 11248 trial, or vaccine trial?
0
Comments
-
I am involved in a vaccine trial; the following excerpt is from a web article by a patient who isShandle said:Sorry..I'd like to know more what this is. Are you trying this out?? ~ Wanda
enrolled in a SU 11248. You can read the entire article at:
http://www.healthtalk.com/coloncancer/programs/060904/page02.cfm
"I'm on a clinical trial on a medication called SU11248, which is oral. [I take] one pill a day for 28 days and then two weeks off. Within two weeks, my cough disappeared and my CEA levels started to drop significantly. [My] energy is coming back, and things are getting back to normal - things are looking good. [Medical editor's note: SU11248 is an experimental drug in clinical trials for various cancers. It is designed to interfere with certain proteins called tyrosine kinases. Signals from these tyrosine kinases promote the development and sustain the growth of some cancers."0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.8K Cancer specific
- 2.8K Anal Cancer
- 446 Bladder Cancer
- 309 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 397 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 671 Leukemia
- 792 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 237 Multiple Myeloma
- 7.1K Ovarian Cancer
- 61 Pancreatic Cancer
- 487 Peritoneal Cancer
- 5.5K Prostate Cancer
- 1.2K Rare and Other Cancers
- 538 Sarcoma
- 730 Skin Cancer
- 653 Stomach Cancer
- 191 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards